[Anti-inflammatory action of nonachlazine, a new circulatory drug].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005334:Fever / Q000188:drug therapy; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D008297:Male; D009628:Nonachlazine / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D000893:Anti-Inflammatory Agents; D010640:Phenothiazines; D009628:Nonachlazine
Działanie przeciwzapalne nonachłazyny - nowego leku krazeniowego.